FDA releases fraudulent H1N1 flu virus product list

NewsGuard 100/100 Score

The U.S. Food and Drug Administration is enforcing the laws that protect consumers from illegal products marketed through the Internet that claim to diagnose, prevent, mitigate, treat or cure the 2009 H1N1 flu virus.

On May 1, 2009, the FDA warned consumers regarding products related to the 2009 H1N1 flu virus offered on the Internet. The products involved are those that are promoted and marketed to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus but are not approved, cleared, or authorized by the FDA. The agency advised operators of offending Web sites that they must take immediate action to ensure that they are not marketing products intended to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus that have not been cleared, approved, or authorized by the FDA.

Since then, the FDA has issued more than 50 warning letters to offending Web sites and as a result, more than 66 percent of these Web sites have removed the offending claims and/or products.

"We are committed to aggressively pursuing those who attempt to take advantage of a public health emergency by promoting and marketing unapproved, uncleared, or unauthorized products," said Margaret A. Hamburg, M.D., Commissioner of Food and Drugs. "We have achieved some success and will remain vigilant in our efforts to protect consumers from these fraudulent, potentially dangerous products."

Examples of unapproved, uncleared, or unauthorized products targeted by the FDA include:

  • A shampoo that claimed to protect against the H1N1 flu virus;
  • A dietary supplement that claimed to protect infants and young children from contracting the H1N1 flu virus;
  • A "new" supplement that claimed to cure H1N1 flu infection within four to eight hours;
  • A spray that claimed to leave a layer of ionic silver on one's hands that killed the virus;
  • Several tests that have not been approved to detect the H1N1 flu virus; and
  • An electronic instrument costing thousands of dollars that claimed to utilize "photobiotic energy" and "deeply penetrating mega-frequency life-force energy waves" to strengthen the immune system and prevent symptoms associated with H1N1 viral infection.

The FDA's warning letters are consistent with an aggressive strategy the agency put into place to protect consumers from individuals or businesses that promote fraudulent claims for products in an attempt to take advantage of the public's concerns about the 2009 H1N1 flu virus.

Unapproved, uncleared, or unauthorized products that claim to diagnose, mitigate, prevent, treat or cure the 2009 H1N1 flu are illegal and a potentially significant threat to the public health.

These warning letters were the result of daily Internet surfs conducted by the FDA's Office of Enforcement, Office of Criminal Investigations, and staff from the Center for Devices and Radiological Health, the Center for Drug Evaluation and Research, and the Center for Food Safety and Applied Nutrition. The warning letters issued by e-mail and the FDA requested a response within 48 hours.

In addition, the FDA posted the offending Web sites and products on the agency's Web site.

"Taking swift action to inform unsuspecting consumers about products that could be dangerous to their health is a major priority for the FDA," said Hamburg.

The FDA will consider further civil or criminal enforcement action against those Web sites that fail to resolve the violations cited in warning letters. Actions could include seizure, injunction, and criminal prosecution.

For more information: FDA's Fraudulent H1N1 Flu Virus Product List

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CDC studies show effectiveness of flu vaccines across all age groups